Trials / Completed
CompletedNCT02067286
Detection of Influenza A, Influenza B, and RSV Using the Liat™ Assays on the Liat™ Analyzer
Multi-Center Study of In Vitro Diagnostic Devices for the Detection of Influenza A, Influenza B, and RSV
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,642 (actual)
- Sponsor
- IQuum, Inc. · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The objective of this study is to evaluate the clinical sensitivity and specificity of the Liat™ Influenza A/B \& RSV Assay and the Liat™ Influenza A/B Assay when used on the Liat Analyzer to detect the presence or absence of Influenza A, Influenza B, and RSV in a nasopharyngeal swab specimen as compared to an FDA approved NAAT and culture.
Conditions
Timeline
- Start date
- 2014-01-01
- Primary completion
- 2015-04-01
- Completion
- 2015-04-01
- First posted
- 2014-02-20
- Last updated
- 2016-08-31
Locations
8 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02067286. Inclusion in this directory is not an endorsement.